Urologic Chronic Pelvic Pain Syndrome

Primary Care - Clinics in Office Practice

Volumn 37, Issue 3, 2010, Pages 527-546

  Martinez Bianchi, Viviana ^a   Halstater, Brian H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder pain syndrome; Dysuria; Interstitial cystitis; Urgency; Urologic chronic pelvic pain syndrome

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; ARGININE; ASTROGLIDE; BCG VACCINE; BOTULINUM TOXIN A; CHONDROITIN SULFATE; CIMETIDINE; CYCLOBENZAPRINE; CYCLOSPORIN A; DIMETHYL SULFOXIDE; DULOXETINE; HEPARIN; HERBACEOUS AGENT; HYALURONIC ACID; HYDROXYZINE; LIDOCAINE; LUBRICATING AGENT; METAXALONE; MONTELUKAST; OXYBUTYNIN; PENTOSAN POLYSULFATE; PETROLATUM; PLACEBO; POLYCARBOPHIL; POTASSIUM; PREDNISONE; PREGABALIN; RESINIFERATOXIN; TIZANIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZESTRA;

ANAMNESIS; BEDTIME DOSAGE; BLADDER TRAINING; BURNING SENSATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CYSTALGIA; CYSTITIS; CYSTOSCOPY; DIET THERAPY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; DYSPAREUNIA; DYSURIA; HUMAN; INTERSTITIAL CYSTITIS; LASER SURGERY; LOW DRUG DOSE; MENTAL DISEASE; MENTAL HEALTH; MYOFASCIAL PAIN; NUTRITIONAL STATUS; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; PELVIC FLOOR MUSCLE TRAINING; PELVIS PAIN SYNDROME; PENIS DISEASE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SELF MONITORING; SEMEN ABNORMALITY; SEX DIFFERENCE; SEX THERAPY; SEXUAL BEHAVIOR; SPASTICITY; UNSPECIFIED SIDE EFFECT; URINARY FREQUENCY; URINARY URGENCY; URINE CULTURE; URINE CYTOLOGY; URODYNAMICS; VAGINAL DRYNESS; XEROSTOMIA;

EID: 77955501747     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2010.05.002     Document Type: Review

References (86)

1. van de Merwe J., Nordling J., Bouchelouche P., et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC. Eur Urol 2008, 53:60-67.
2. Bogart L.M., Berry S.H., Clemens J.Q. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 2007, 177(2):450-456.
3. Hanno P.M. Painful bladder syndrome/interstitial cystitis and related disorders. Campbell-Walsh urology 2007, 330-370. Saunders, Philadelphia. 9th edition. A.J. Wein (Ed.).
4. Hanno P.M., Landis J.R., Mathews-Cook Y., et al. The diagnosis of interstitial cuystitis revisited: lessons learned from the NIH Interstitial Cistitis Database Study. J Urol 1999, 161(2):553-557.
5. Sant G.R., Hanno P.M. Interstitial cystitis: current issues and controversies in diagnosis. Urology 2001, 6(1):82-88.
6. Anderson R.U., Sawyer T., Wise D., et al. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009, 182(6):2753-2758.
7. Warren J.W., Langenberg P., Greenberg P., et al. Sites of pain from interstitial cystitis/painful bladder syndrome. J Urol 2008, 180(4):1373-1377.
8. Hanno P.M. Interstitial cystitis-epidemiology, diagnostic criteria, clinical markers. Rev Urol 2002, 4(Suppl 1):S3-S8.
9. Abrams P., Baranowski A., Berger R., et al. A new classification is needed for pelvic pain syndromes-are existing terminologies of spurious diagnostic authority bad for patients?. J Urol 2006, 175(6):1989-1990.
10. Rosenberg M., Hazzard M. Prevalence of Interstitial cystitis symptoms in women: a population based study in the primary care office. J Urol 2005, 174(6):2231-2234.
11. Leppilahti, Sairanen J., Tammela T.L., et al. Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland. J Urol 2005, 174(2):407-801. Finnish Interstitial Cystitis-Pelvic Pain Syndome Study Group.
12. Clemens J., Meenan R., O'Keeffe-Rosetti M., et al. Prevalence of prostatitis-like symptoms in a managed care population. J Urol 2005, 176(2):576-580.
13. Doggweiler-Wiygul R. Urologic myofascial pain syndromes. Curr Pain Headache Rep 2004, 8:445-451.
14. Warren J.W., Brown V., Jacobs S., et al. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008, 71(6):1085-1090.
15. Al-Hadithi H.N., Williams H., Hart C.A., et al. Absence of bacterial and viral DNA in bladder biopsies from patients with interstitial cystitis/chronic pelvic pain syndrome. J Urol 2005, 174(1):151-154.
16. Hurst R.E., Rhodes S.W., Adamson P.B., et al. Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 1987, 138(1):433-437.
17. Dupont M.C., Spitsbergen J.M., Kim K.B., et al. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 2001, 166(3):1111-1118.
18. Mukerji G., Yiangou Y., Agarwal S.K., et al. Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 2006, 176(2):797-801.
19. Ness T.J., Powell-Boone T., Cannon R., et al. Psychophysical evidence of hypersensitivity in subjects with interstitial cystitis. J Urol 2005, 173(6):1983-1987.
20. Fitzgerald M.P., Anderson R.U., Potts J., et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2009, 182(2):570-580. Urological Pelvic Pain Collaborative Research Network.
21. Pezzone M.A., Liang R., Fraser M.O. A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders. Gastroenterology 2005, 128(7):1953-1964.
22. Noronha R., Akbarali H., Malykhina A., et al. Changes in urinary bladder smooth muscle function in response to colonic inflammation. Am J Physiol Renal Physiol 2007, 293(5):1461-1467.
23. FitzGerald M.P., Brensinger C., Brubaker L., et al. What is the pain of interstitial cystitis like?. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17(1):69-72.
24. Powell-Boone T., Ness T.J., Cannon R., et al. Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis. J Urol 2005, 174(5):1832-1836.
25. Kushner L., Moldwin R.M. Efficiency of questionnaires used to screen for interstitial cystitis. J Urol 2006, 176(2):587-592.
26. O'Leary M.P., Sant G.R., Fowler F.J., et al. The interstitial cystitis symptom index and problem index. Urology 1997, 49(Suppl 5A):58-63.
27. Parsons C.L., Dell J., Stanford E.J., et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002, 60(4):573-578.
28. Litwin M.S., McNaughton-Collins M., Fowler F.J., et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 162(2):369-375.
29. Nordling J., Anjum F., Bade J., et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 2004, 45(5):535-682.
30. Clemens J.Q., Joyce G.F., Wise M., et al. Interstitial cystitis and painful bladder syndrome. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2007, 125-154. US Government Printing Office, Washington, DC, NIH Publication # 07-5512. M.S. Litwin, C.S. Saigal (Eds.).
31. Warren J.W., Howard F.M., Cross R.K., et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009, 73(1):52-57.
32. Peters K.M., Kalinowski S.E., Carrico D.J., et al. Fact or fiction-is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population. J Urol 2007, 178(3 Pt 1):891-895.
33. Dimitrakov J., Guthrie D. Genetics and phenotyping of urological chronic pelvic pain syndrome. J Urol 2009, 181(4):1550-1557.
34. Gardella B., Porru D., Ferdeghini F., et al. Insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome. Eur Urol 2008, 54(5):1145-1151.
35. Peters K.M., Carrico D.J., Diokno A.C. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology 2008, 71(4):634-640.
36. Kahn B.S., Tatro C., Parsons C.L., et al. Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity. J Sex Med 2010, 7:996-1002.
37. Ohl L. Essentials of female sexual dysfunction from a sex therapy perspective. Urol Nurs 2007, 27(1):57-63.
38. Goldstein I. Urologic management of women with sexual health concerns. Wein: Campbell-Walsh urology 2007, Saunders, Philadelphia, Chapter 28. A.J. Wein (Ed.).
39. Shorter B., Lesser M., Moldwin R.M., et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol 2007, 178(1):145-152.
40. Nickel J.C., Tripp D.A., Pontari M., et al. Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case-control study. J Urol 2010, 183(1):167-172.
41. Nickel J.C., Payne C.K., Forrest J., et al. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. J Urol 2009, 181(6):2555-2561.
42. Shoskes D.A., Nickel J.C., Rackley R.R., et al. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome: a phenotypic classification of UCPPS. Prostate Cancer Prostatic Dis 2009, 12:177-183.
43. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
44. Sullivan M.J.L., Bishop S., Pivik J., et al. The pain catastrophizing scale: development and validation. Psychol Assess 1995, 7(4):524-532.
45. Weiss J.M. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166(6):2226-2231.
46. Irwin P., Samsudin A. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common. J Urol 2005, 174(2):584-587.
47. Neal D.E. Interstitial cystitis: evaluation and related conditions. J Urol 2009, 181(6):2414-2415.
48. Tissot W.D., Diokno A.C., Peters K.M. A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004, 172(2):478-480.
49. Wein A. Primary evaluation of patients suspected of having interstitial cystitis (IC). J Urol 2004, 172(6):2494-2495.
50. Kim S.H., Kim T.B., Kim S.W., et al. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder. J Urol 2009, 181(6):2550-2554.
51. Parsons C.L., Bullen M., Kahn B.S., et al. Gynecologic presentation of interstitial cystitis as detected by intravesical potassium sensitivity. Obstet Gynecol 2001, 98(1):127-132.
52. van Ophoven A., Hertle L. Long term results of amitripyline treatment for interstitial cystitis. J Urol 2005, 174(5):1837-1840.
53. van Ophoven A., Pokupic S., Heinecke A., et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004, 172(2):533-536.
54. Nickel J.C., Barkin J., Forrest J., et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005, 65(4):654-658. Elmiron Study Group.
55. Nickel J.C., Kaufman D.M., Zhang H.F., et al. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology 2008, 71(1):57-61.
56. Sairanen J., Tammela T.L., Leppilahti M., et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2005, 174(6):2235-2238.
57. Thilagarajah R., Witherow R.O., Walker M.M. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 2001, 87(3):207-212.
58. Korting G.E., Smith S.D., Wheeler M.A., et al. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol 1999, 161(2):558-565.
59. Sant G.R., Propert K.J., Hanno P.M., et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. The Interstitial Cystitis Clinical Trials Group. J Urol 2003, 170(3):810-815.
60. Soucy F., Grégoire M. Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J Urol 2005, 173(3):841-843.
61. Butrick C.W. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am 2009, 36(3):707-722.
62. Bouchelouche K., Nordling J., Hald T., et al. The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis. J Urol 2001, 166(5):1734-1737.
63. van Ophoven A., Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J Urol 2007, 177(2):552-555.
64. Dawson T.E., Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev 2007, 4. CD006113.
65. Welk B.K., Teichman J.M. Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology 2008, 71(1):67-70.
66. Parsons C.L. Successful down-regulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005, 65(1):45-48.
67. Nickel J.C., Moldwin R., Lee S., et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009, 103(7):910-918.
68. Mayer R., Propert K.J., Peters K.M., et al. A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis. The Interstitial cystitis CLinical trials Group. J Urol 2005, 173:1186-1191.
69. Propert K.J., Mayer R., Nickel J.C., et al. Follow-up of patients with interstitial cystitis responsive to treatment with intravesical bacillus calmette-guerin or placebo. J Urol 2008, 179.
70. Mayer R., Propert K.J., Peters K.M., et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. J Urol 2005, 173(4):1186-1191.
71. Lazzeri M., Beneforti P., Spinelli M., et al. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 2000, 164(3 Pt 1):676-679.
72. Anderson L., Lewis S.E., McClure N. The effects of coital lubricants on sperm motility in vitro. Hum Reprod 1998, 13:3351-3356.
73. Haefner H.K., Collins M.E., Davis G.D., et al. The vulvodynia guideline. J Low Genit Tract Dis 2005, 9(1):40-51.
74. Clayton A., Hamilton D. Female sexual dysfunction. Psychiatr Clin North Am 2010, 33(2):323-338.
75. Ferguson D.M., Steidle C.P., Singh G.S., et al. Randomized, placebo-controlled, double-blind, crossover design trial of the efficacy and safety of " Zestra for Women" in women with and without female sexual arousal disorder. J Sex Marital Ther 2003, 29(Suppl 1):33-44.
76. Whitmore K.E. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol 2002, 4(Suppl 1):S28-S35.
77. Rothrock N.E., Lutgendorf S.K., Kreder K.J. Coping strategies in patients with interstitial cystitis: relationships with quality of life and depression. J Urol 2003, 169(1):233-236.
78. Nickel J.C., Tripp D., Teal V., et al. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol 2007, 177(5):1832-1836. Interstitial Cystitis Collaborative Trials Group.
79. Rovner E., Propert K.J., Brensinger C., et al. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology 2000, 56(6):940-945.
80. Powell C.R., Kreder K.J. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 2010, 183(1):173-176.
81. Rofeim O., Hom D., Freid R.M., et al. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol 2001, 166(1):134-136.
82. Webster D.C., Brennan T. Interstitial cystitis. Arch Gynecol Obstet 2007, 275(4):223-229.
83. Abbott J.A., Jarvis S.K., Lyons S.D., et al. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol 2006, 108(4):915-923.
84. Marinkovic S.P., Moldwin R., Gillen L.M., et al. The management of interstitial cystitis or painful bladder syndrome in women. BMJ 2009, 339:b2707.
85. Rothrock N.E., Lutgendorf S.K., Hoffman A., et al. Depressive symptoms and quality of life in patients with interstitial cystitis. J Urol 2002, 167(4):1763-1767.
86. Forrest J.B., Dell J.R. Successful management of interstitial cystitis in clinical practice. Urology 2007, 69(Suppl 4):82-86.